(Q36946007)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880620%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

review article

1 reference

title

Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880620%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

0 references

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880620%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Thomas E Delea

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880620%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

John Edelsberg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880620%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Oleg Sofrygin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880620%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Simu K Thomas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880620%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Jean-Francois Baladi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880620%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Pradyumna D Phatak

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880620%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880620%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880620%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880620%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880620%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

1919-1929

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880620%20AND%20SRC:MED&resulttype=core&format=json

Pharmacosurveillance and quality of care of thalassaemic patients. A large scale epidemiological survey

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01416.X

Deferiprone versus deferoxamine in patients with thalassemia major: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01416.X

Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01416.X

Development of tridentate iron chelators: from desferrithiocin to ICL670.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01416.X

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01416.X

Modeling for health care and other policy decisions: uses, roles, and validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01416.X

Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01416.X

An investigation into variability in the therapeutic response to deferiprone in patients with thalassemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01416.X

Comparison between deferoxamine and deferiprone (L1) in iron-loaded thalassemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01416.X

Monitoring long-term efficacy of iron chelation therapy by deferiprone and desferrioxamine in patients with beta-thalassaemia major: application of SQUID biomagnetic liver susceptometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01416.X

Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01416.X

Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01416.X

Left ventricular remodelling, and systolic and diastolic function in young adults with beta thalassaemia major: a Doppler echocardiographic assessment and correlation with haematological data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01416.X

Iron chelation with deferoxamine: comparing the results of a critical pathway to a national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01416.X

Complications of beta-thalassemia major in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01416.X

Congestive heart failure in the community: trends in incidence and survival in a 10-year period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01416.X

Heart failure in beta thalassemia: a 5-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01416.X

Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01416.X

Cost effectiveness of once-daily oral chelation therapy with deferasirox versus infusional deferoxamine in transfusion-dependent thalassaemia patients: US healthcare system perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01416.X

10.1111/J.1537-2995.2007.01416.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880620%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference